Frontiers Association of Lipoprotein(a)-Associated Mortality and

Por um escritor misterioso

Descrição

Frontiers  Association of Lipoprotein(a)-Associated Mortality and
A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies - ScienceDirect
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Frontiers Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Clinical Feature: The ABCs of Lipoprotein(a)
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Frontiers Serum lipoprotein (a) associates with the risk of renal function damage in the CHCN-BTH Study: Cross-sectional and Mendelian randomization analyses
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Kaplan–Meier survival curves according to tertiles of lipoprotein (a)
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Frontiers Lipoprotein(a) induces caspase-1 activation and IL-1 signaling in human macrophages
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
JCM, Free Full-Text
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Lipoprotein(a) distribution and its association with carotid arteriopathy in the Chinese population - ScienceDirect
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Frontiers Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Frontiers Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Frontiers Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Frontiers The U-shaped association of non-high-density lipoprotein cholesterol with all-cause and cardiovascular mortality in general adult population
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Association of Lipoprotein (a) With Coronary-Computed Tomography Angiography–Assessed High-Risk Coronary Disease Attributes and Cardiovascular Outcomes
Frontiers  Association of Lipoprotein(a)-Associated Mortality and
Frontiers The Evolving Understanding and Approach to Residual Cardiovascular Risk Management
de por adulto (o preço varia de acordo com o tamanho do grupo)